Study of HCD122 (Lucatumumab) and Bendamustine Combination Therapy in CD40+ Rituximab-refractory Follicular Lymphoma

Update Il y a 4 ans
Reference: NCT01275209

Woman and Man

Extract

This study will assess the safety and efficacy of HCD122 (Lucatumumab) when combined with bendamustine in patients with follicular lymphoma.


Inclusion criteria

  • Follicular lymphoma


Links